This HTML5 document contains 187 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0121240/
n20	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n17	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0121240/core-reimbursement/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0121240/price/
n3	http://linked.opendata.cz/ontology/sukl/
n10	http://linked.opendata.cz/resource/sukl/specialization-restriction/
skos	http://www.w3.org/2004/02/skos/core#
n16	http://linked.opendata.cz/resource/sukl/indgroup/
n8	http://linked.opendata.cz/resource/sukl/packing/
n9	http://linked.opendata.cz/resource/sukl/company/
n19	http://linked.opendata.cz/resource/sukl/active-ingredient/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://linked.opendata.cz/resource/sukl/registration-state/
n11	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0121240/price-of-originator/
xsdh	http://www.w3.org/2001/XMLSchema#
n6	http://www.sukl.cz/modules/medication/
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0121240/reimbursement/
n18	http://linked.opendata.cz/resource/sukl/df/
n13	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0121240

rdf:type

n3:MedicinalProductPackaging

dcterms:title

CEFTRIAXON KABI 2 G

skos:notation

0121240

n3:hasATCCode

n13:J01DD04

n3:hasActiveIngredient

n19:CEFTRIAXONUM-DINATRICUM-TRIHEMIHYDRICUM

n3:hasDefinedDailyDose

n4:ddd

n3:hasDosageForm

n18:PLV-SOL-INF

n3:hasPackagingSize

10

n3:hasPacking

n8:VIA

n3:hasRegistrationHolder

n9:FRKCZ

n3:hasRegistrationState

n12:R

n3:hasRouteOfAdministration

n20:INF

n3:hasStrength

2GM

n3:hasIndicationGroup

n16:15

n3:hasSpecializationRestriction

n10:ATB

n3:containsDefinedDailyDoses

10.0

n3:hasRegistrationCode

15/ 101/08-C

n3:hasTitleSupplement

INF PLV SOL 10X2GM

n3:containsUsualTherapeuticalDailyDoses

10

n3:hasCoreReimbursementSpecification

n17:2013-12-01 n17:2014-01-01 n17:2013-10-01 n17:2013-11-01 n17:2014-04-01 n17:2014-05-01 n17:2014-02-01 n17:2014-03-01 n17:2014-07-01 n17:2014-07-03 n17:2014-06-01 n17:2014-06-13 n17:2014-10-01 n17:2014-10-02 n17:2014-08-01 n17:2014-09-01 n17:2013-01-05 n17:2013-02-01 n17:2013-01-01 n17:2013-05-01 n17:2013-06-01 n17:2013-03-01 n17:2013-04-01 n17:2013-08-03 n17:2013-09-01 n17:2013-07-01 n17:2013-08-01 n17:2014-12-01 n17:2015-01-01 n17:2014-11-01 n17:2014-11-19 n17:2015-03-01 n17:2015-04-01 n17:2015-01-13 n17:2015-02-01 n17:2015-06-01 n17:2015-07-01 n17:2015-04-02 n17:2015-05-01 n17:2015-07-02

n3:hasPriceOfOriginatorSpecification

n11:2015-03-01 n11:2015-04-01 n11:2015-01-13 n11:2015-02-01 n11:2014-12-01 n11:2015-01-01 n11:2014-11-01 n11:2014-11-19 n11:2014-10-01 n11:2014-10-02 n11:2014-08-01 n11:2014-09-01 n11:2014-07-01 n11:2014-07-03 n11:2014-06-01 n11:2014-06-13 n11:2015-07-02 n11:2015-06-01 n11:2015-07-01 n11:2015-04-02 n11:2015-05-01 n11:2013-01-05 n11:2013-02-01 n11:2013-01-01 n11:2014-04-01 n11:2014-05-01 n11:2014-02-01 n11:2014-03-01 n11:2013-12-01 n11:2014-01-01 n11:2013-10-01 n11:2013-11-01 n11:2013-08-03 n11:2013-09-01 n11:2013-07-01 n11:2013-08-01 n11:2013-05-01 n11:2013-06-01 n11:2013-03-01 n11:2013-04-01

n3:hasPriceSpecification

n7:2014-06-01 n7:2014-06-13 n7:2014-07-01 n7:2014-07-03 n7:2014-08-01 n7:2014-09-01 n7:2014-10-01 n7:2014-10-02 n7:2013-10-01 n7:2013-11-01 n7:2013-12-01 n7:2014-01-01 n7:2014-02-01 n7:2014-03-01 n7:2014-04-01 n7:2014-05-01 n7:2015-04-02 n7:2015-05-01 n7:2015-06-01 n7:2015-07-01 n7:2015-07-02 n7:2014-11-01 n7:2014-11-19 n7:2014-12-01 n7:2015-01-01 n7:2015-01-13 n7:2015-02-01 n7:2015-03-01 n7:2015-04-01 n7:2013-03-01 n7:2013-04-01 n7:2013-05-01 n7:2013-06-01 n7:2013-07-01 n7:2013-08-01 n7:2013-08-03 n7:2013-09-01 n7:2013-01-01 n7:2013-01-05 n7:2013-02-01

n3:hasReimbursementSpecification

n5:2015-06-01 n5:2015-07-01 n5:2015-04-02 n5:2015-05-01 n5:2015-07-02 n5:2013-12-01 n5:2014-01-01 n5:2013-10-01 n5:2013-11-01 n5:2014-04-01 n5:2014-05-01 n5:2014-02-01 n5:2014-03-01 n5:2013-05-01 n5:2013-06-01 n5:2013-03-01 n5:2013-04-01 n5:2013-08-03 n5:2013-09-01 n5:2013-07-01 n5:2013-08-01 n5:2014-12-01 n5:2015-01-01 n5:2014-11-01 n5:2014-11-19 n5:2015-03-01 n5:2015-04-01 n5:2015-01-13 n5:2015-02-01 n5:2014-07-01 n5:2014-07-03 n5:2014-06-01 n5:2014-06-13 n5:2014-10-01 n5:2014-10-02 n5:2014-08-01 n5:2014-09-01 n5:2013-01-05 n5:2013-02-01 n5:2013-01-01

n3:hasResumedMarketingDate

2011-03-08+01:00

n3:hasUsualTherapeuticalDailyDose

n4:utdd

n3:pilFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DPI60696.pdf%26type%3Dpil%26as%3Dceftriaxon-kabi-2-g-pil

n3:pilUri

n6:download.php?file=PI60696.pdf&type=pil&as=ceftriaxon-kabi-2-g-pil

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC35686.pdf%26type%3Dspc%26as%3Dceftriaxon-kabi-2-g-spc

n3:spcUri

n6:download.php?file=SPC35686.pdf&type=spc&as=ceftriaxon-kabi-2-g-spc

n3:textOnTheWrapFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DOBAL57118.pdf%26type%3Dobal%26as%3Dceftriaxon-kabi-2-g-obal

n3:textOnTheWrapUri

n6:download.php?file=OBAL57118.pdf&type=obal&as=ceftriaxon-kabi-2-g-obal